Drug Shortage Report for M-MONTELUKAST
| Report ID | 245411 |
| Drug Identification Number | 02488183 |
| Brand name | M-MONTELUKAST |
| Common or Proper name | M-MONTELUKAST |
| Company Name | MANTRA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MONTELUKAST |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30 |
| ATC code | R03DC |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2024-09-16 |
| Estimated end date | 2024-12-20 |
| Actual end date | 2020-12-20 |
| Shortage status | Avoided shortage |
| Updated date | 2025-01-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-01-03 | French | Compare |
| v3 | 2025-01-03 | English | Compare |
| v2 | 2024-12-11 | French | Compare |
| v1 | 2024-12-11 | English | Compare |
Showing 1 to 4 of 4